PHK
TVRD

Point72 Hong Kong’s Tvardi Therapeutics TVRD Stock Holding History

Point72 Hong Kong’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-101
Closed -$56K – 2482
2021
Q3 		$56K Buy
+101
New +$50.7K ﹤0.01% 1498
2021
Q1 		– Sell
-40
Closed -$22K – 2282
2020
Q4 		$22K Sell
40
-3
-7% -$1.57K ﹤0.01% 1406
2020
Q3 		$20K Buy
+43
New +$25K ﹤0.01% 873
2020
Q1 		– Sell
-63
Closed -$36K – 1428
2019
Q4 		$36K Buy
63
+59
+1,475% +$41.4K 0.01% 763
2019
Q3 		$3K Buy
+4
New +$3.33K ﹤0.01% 852
2017
Q3 		– Sell
-2
Closed -$1K – 1106
2017
Q2 		$1K Buy
+2
New +$1.27K ﹤0.01% 749
2016
Q4 		– Sell
-103
Closed -$31K – 1069
2016
Q3 		$31K Buy
+103
New +$22.3K 0.02% 531

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Point72 Hong Kong's TVRD Position: Q4 2021 in Review

Point72 Hong Kong sold out of Tvardi Therapeutics (TVRD) in Q4 2021, closing a stake of 101 shares — an estimated $56K sold.

Point72 Hong Kong first reported a position in TVRD in Q3 2016 and held it in 7 quarters. The position peaked at $56K in Q3 2021. 180 funds tracked by Wall St. Rank hold TVRD as of Q4 2021.

  • Point72 Hong Kong reported no remaining Tvardi Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 101 Tvardi Therapeutics shares in Q4 2021, an estimated $56K.
  • Point72 Hong Kong first reported a position in Tvardi Therapeutics in Q3 2016 and held it in 7 quarters.
  • Point72 Hong Kong's Tvardi Therapeutics position peaked at $56K in Q3 2021.
  • 180 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.